Perez JR, Hernández R, Lage Y, Rupérez AB, Ruiz E, Hernández T, et al. Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient Treated with a Novel Combination Treatment with Anti PDL1 Antibody (Durvalumab) and VEGFR2 Antibody (Ramucirumab). acmcr [Internet]. 2020 Jan. 2 [cited 2026 Jun. 15];4(1):8-14. Available from: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22266